Merck serono steroids

DIAZEPAM BP 2MG TABLETS (Leaflet)
DIAZEPAM 10 MG TABLETS (Leaflet)
DIAZEPAM 10MG (Leaflet)
DIAZEPAM 10MG TABLETS (Leaflet)
DIAZEPAM 10MG TABLETS . (Leaflet)
DIAZEPAM 2 MG TABLETS (Leaflet)
DIAZEPAM 2MG (Leaflet)
DIAZEPAM 2MG TABLETS (Leaflet)
DIAZEPAM 2MG TABLETS . (Leaflet)
DIAZEPAM 5 MG TABLETS (Leaflet)
DIAZEPAM 5MG (Leaflet)
DIAZEPAM 5MG TABLETS (Leaflet)
DIAZEPAM 5MG TABLETS . (Leaflet)
DIAZEPAM 5MG TABLETS BP (Leaflet)
DIAZEPAM 5MG/ML SOLUTION FOR INJECTION (Leaflet)
DIAZEPAM BP 10MG TABLETS (Leaflet)
DIAZEPAM BP 5MG TABLETS (Leaflet)
DIAZEPAM DESITIN 10MG RECTAL SOLUTION (Leaflet)
DIAZEPAM DESITIN 5MG RECTAL SOLUTION (Leaflet)
DIAZEPAM FORTE SYRUP 5MG/5ML (Leaflet)
DIAZEPAM INJECTION BP (Leaflet)
DIAZEPAM INJECTION BP 10MG/2ML (Leaflet)
DIAZEPAM ORAL SOLUTION BP 2MG/5ML (Leaflet)
DIAZEPAM RECTAL TUBES 10MG (Leaflet)
DIAZEPAM RECTAL TUBES 5MG (Leaflet)
DIAZEPAM RECTUBES 10MG RECTAL SOLUTION (Leaflet)
DIAZEPAM RECTUBES RECTAL SOLUTION (Leaflet)
DIAZEPAM RECTUBES 20MG (Leaflet)
DIAZEPAM RECTUBES 5MG RECTAL SOLUTION (Leaflet)
DIAZEPAM SYRUP 2MG/5ML (Leaflet)
DIAZEPAM TABLETS BP 10MG (Leaflet)
DIAZEPAM TABLETS BP 2MG (Leaflet)
DIAZEPAM TABLETS BP 5MG (Leaflet)

Patients and caregivers who will administer Saizen should receive appropriate training and instruction on the proper use of Saizen from the physician or other suitably qualified health care professional. A puncture-resistant container for the disposal of used syringes and needles should be strongly recommended. Patients and/or parents should be thoroughly instructed in the importance of proper disposal, and cautioned against any reuse of needles and syringes. This information is intended to aid in the safe and effective administration of the medication.

This work was supported by the National Multiple Sclerosis Society; the National Multiple Sclerosis Society/American Brain Foundation Clinician Scientist Award; the Harvard Catalyst/The Harvard Clinical and Translational Science Center; the National Center for Research Resources; the National Center for Advancing Translational Sciences, National Institutes of Health; Harvard University and its affiliated academic health care centers. Some of the authors of the study disclosed competing interests involving a variety of commercial entities including Merck Serono, Novartis, Teva Neurosciences, Biogen Idec, EMD Serono, and Sanofi Aventis. Neither commentator, Dr. Voskuhl nor Dr. Baker, has disclosed potential conflicts of interest relative to this paper.

It was the ethical questions that were new. Is GH not a wise use of finite healthcare resources, or is the physician’s primary responsibility to the patient? If GH is given to most extremely short children to make them taller, will the definition of “extremely short” simply rise, negating the expected social benefit? If GH is given to short children whose parents can afford it, will shortness become a permanent mark of lower social origins? More of these issues are outlined in the ethics section. Whole meetings were devoted to these questions; pediatric endocrinology had become a specialty with its own bioethics issues.

Merck serono steroids

merck serono steroids

It was the ethical questions that were new. Is GH not a wise use of finite healthcare resources, or is the physician’s primary responsibility to the patient? If GH is given to most extremely short children to make them taller, will the definition of “extremely short” simply rise, negating the expected social benefit? If GH is given to short children whose parents can afford it, will shortness become a permanent mark of lower social origins? More of these issues are outlined in the ethics section. Whole meetings were devoted to these questions; pediatric endocrinology had become a specialty with its own bioethics issues.

Media:

merck serono steroidsmerck serono steroidsmerck serono steroidsmerck serono steroidsmerck serono steroids